Sign In

Peter Harris

Partner at University Growth Fund

Peter Harris is an accomplished professional currently serving in Strategic Partnerships at Verily, previously known as Google Life Sciences.

With a background in Biomedical Engineering, Peter has a wealth of experience in executing deals, including mergers and acquisitions, equity investments, licensing agreements, and partnerships.

He played a vital role in Varian's strategic transformation, ultimately leading to its acquisition by Siemens Healthineers for $16.4B.

Across various investing roles, Peter has facilitated 7 successful exits to date, including companies like Fusion Pharma, Grail, and Lyft.

Peter's entrepreneurial spirit led him to found Xenocor, a surgical medtech company specializing in innovative laparoscopy solutions.

In academia, Peter holds a PhD in Biomedical Engineering with a focus on Computational Neurology, complementing his business acumen.

His educational journey includes studies in Economics and International Business at Brigham Young University, where he also engaged in leadership roles and teaching assistantships.

Peter's professional history encompasses diverse roles such as Board Director, Partner, Consultant, Project Manager, and Intern at respected organizations like Cidi Labs, Fairbourne Consulting, and Citi Group.

His involvement with the University Growth Fund and University Venture Fund underscores his commitment to fostering innovation and growth within the academic and entrepreneurial spheres.

Peter Harris
Add to my network

Location

Salt Lake City, Utah, United States